Annual report pursuant to Section 13 and 15(d)

Intangible Assets

v2.4.0.6
Intangible Assets
 12 Months Ended
Mar. 31, 2013
Intangible Assets [Abstract]  
Intangible Assets
Note 3. Intangible Assets

With the acquisition of CollabRx, as of March 31, 2013, the Company's intangible assets net value was $1,490.  The Company does not amortize the Trade Name as it has an indefinite life subject to annual impairment tests. The net book value of Goodwill was $603.
 
As of March 31, 2013, intangible assets, net consisted of the following: 
 
Accumulated
Gross
Amortization
Net
Developed Technology
$
719
$
(56
 )
$
663
Customer Relationships
433
(65
 )
368
Trade Name
346
-
346
Non Compete Agreement
151
(38
)
113
 
Total
$
1,649
$
(159
 )
$
1,490

Amortization expense was $160 and $0 in fiscal 2013 and 2012, respectively.
 
Year Ending March 31,
 
Estimated Amortization Expense
 
2014
 
$
209
 
2015
 
 
209
 
2016
 
 
171
 
2017
 
 
159
 
2018
 
 
94
 
Thereafter
 
 
648
 
 
$
1,490
 
 
The Company sold all remaining intangibles, except the NLD related patents, to SPTS on February 9, 2011.  The Company retained the internally developed NLD patents and has sold all but nine of those patents to third parties as of March 31, 2013.  The remaining patents are being offered for sale to third parties.  These assets have a net value of zero as they were internally developed.